Arrowstreet Capital, Limited Partnership Bio Rad Laboratories, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

  • $122 Billion
  • Q4 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 36,956 shares of BIO stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
36,956
Previous 7,249 409.81%
Holding current value
$10.2 Million
Previous $2.43 Million 400.62%
% of portfolio
0.01%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$313.15 - $374.28 $9.3 Million - $11.1 Million
29,707 Added 409.81%
36,956 $12.1 Million
Q3 2024

Nov 14, 2024
BUY
$263.97 - $344.64 $1.91 Million - $2.5 Million
7,249 New
7,249 $2.43 Million
Q1 2024

May 15, 2024
BUY
$304.11 - $351.99 $2.73 Million - $3.16 Million
8,972 New
8,972 $3.1 Million
Q1 2023

May 15, 2023
SELL
$418.69 - $503.0 $9.52 Million - $11.4 Million
-22,745 Reduced 65.83%
11,804 $5.65 Million
Q4 2022

Feb 14, 2023
BUY
$351.71 - $456.01 $534,950 - $693,591
1,521 Added 4.61%
34,549 $14.5 Million
Q3 2022

Nov 14, 2022
BUY
$412.59 - $563.26 $2.26 Million - $3.09 Million
5,487 Added 19.92%
33,028 $13.8 Million
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $26.2 Million - $33.8 Million
-56,567 Reduced 67.26%
27,541 $13.6 Million
Q1 2022

May 13, 2022
BUY
$524.57 - $735.42 $892,293 - $1.25 Million
1,701 Added 2.06%
84,108 $47.4 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $5.46 Million - $6.12 Million
-7,704 Reduced 8.55%
82,407 $62.3 Million
Q3 2021

Nov 12, 2021
BUY
$657.71 - $825.77 $188,762 - $236,995
287 Added 0.32%
90,111 $67.2 Million
Q2 2021

Aug 13, 2021
BUY
$576.64 - $649.04 $17.6 Million - $19.8 Million
30,572 Added 51.6%
89,824 $57.9 Million
Q1 2021

May 14, 2021
BUY
$547.01 - $662.35 $8.68 Million - $10.5 Million
15,859 Added 36.55%
59,252 $33.8 Million
Q4 2020

Feb 12, 2021
BUY
$510.68 - $643.45 $11.3 Million - $14.3 Million
22,176 Added 104.52%
43,393 $25.3 Million
Q3 2020

Nov 12, 2020
BUY
$454.43 - $535.6 $2.15 Million - $2.53 Million
4,724 Added 28.64%
21,217 $10.9 Million
Q2 2020

Aug 12, 2020
SELL
$334.87 - $493.06 $1.67 Million - $2.47 Million
-5,000 Reduced 23.26%
16,493 $7.45 Million
Q1 2020

May 15, 2020
BUY
$320.01 - $409.07 $4.9 Million - $6.26 Million
15,303 Added 247.22%
21,493 $7.54 Million
Q4 2019

Feb 13, 2020
SELL
$319.73 - $374.2 $4.09 Million - $4.79 Million
-12,807 Reduced 67.42%
6,190 $2.29 Million
Q3 2019

Nov 14, 2019
SELL
$304.55 - $345.24 $10.6 Million - $12 Million
-34,752 Reduced 64.66%
18,997 $6.32 Million
Q2 2019

Aug 14, 2019
SELL
$286.93 - $312.59 $3.34 Million - $3.64 Million
-11,657 Reduced 17.82%
53,749 $16.8 Million
Q1 2019

May 15, 2019
BUY
$224.3 - $317.41 $9.81 Million - $13.9 Million
43,752 Added 202.05%
65,406 $20 Million
Q4 2018

Feb 14, 2019
BUY
$220.1 - $309.0 $3.27 Million - $4.59 Million
14,854 Added 218.44%
21,654 $5.03 Million
Q3 2018

Nov 14, 2018
BUY
$289.28 - $326.15 $1.97 Million - $2.22 Million
6,800 New
6,800 $2.13 Million
Q2 2018

Aug 14, 2018
SELL
$244.1 - $303.88 $2.44 Million - $3.04 Million
-10,000 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$233.97 - $274.11 $280,764 - $328,932
1,200 Added 13.64%
10,000 $2.5 Million
Q4 2017

Feb 09, 2018
BUY
$216.94 - $271.3 $1.17 Million - $1.47 Million
5,400 Added 158.82%
8,800 $2.1 Million
Q3 2017

Nov 14, 2017
BUY
$212.27 - $242.28 $721,718 - $823,752
3,400
3,400 $756,000

Others Institutions Holding BIO

# of Institutions
480
Shares Held
19.6M
Call Options Held
15.5K
Put Options Held
12.3K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.83B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email